132 related articles for article (PubMed ID: 7914192)
1. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells.
Scott GK; Daniel JC; Xiong X; Maki RA; Kabat D; Benz CC
J Biol Chem; 1994 Aug; 269(31):19848-58. PubMed ID: 7914192
[TBL] [Abstract][Full Text] [Related]
2. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides.
Chiang SY; Burli RW; Benz CC; Gawron L; Scott GK; Dervan PB; Beerman TA
J Biol Chem; 2000 Aug; 275(32):24246-54. PubMed ID: 10818092
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
4. An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene.
Pastorcic M; Das HK
J Biol Chem; 1999 Aug; 274(34):24297-307. PubMed ID: 10446206
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.
D'Orazio D; Besser D; Marksitzer R; Kunz C; Hume DA; Kiefer B; Nagamine Y
Gene; 1997 Nov; 201(1-2):179-87. PubMed ID: 9409785
[TBL] [Abstract][Full Text] [Related]
7. Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.
Schweppe RE; Gutierrez-Hartmann A
Nucleic Acids Res; 2001 Mar; 29(5):1251-60. PubMed ID: 11222776
[TBL] [Abstract][Full Text] [Related]
8. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
9. An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter.
Rosen GD; Barks JL; Iademarco MF; Fisher RJ; Dean DC
J Biol Chem; 1994 Jun; 269(22):15652-60. PubMed ID: 8195215
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
Chan YJ; Chiou CJ; Huang Q; Hayward GS
J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
[TBL] [Abstract][Full Text] [Related]
11. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.
Boehlk S; Fessele S; Mojaat A; Miyamoto NG; Werner T; Nelson EL; Schlöndorff D; Nelson PJ
Eur J Immunol; 2000 Apr; 30(4):1102-12. PubMed ID: 10760799
[TBL] [Abstract][Full Text] [Related]
12. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein.
Cardot P; Pastier D; Lacorte JM; Mangeney M; Zannis VI; Chambaz J
Biochemistry; 1994 Oct; 33(40):12139-48. PubMed ID: 7918435
[TBL] [Abstract][Full Text] [Related]
14. Ets regulation of the erbB2 promoter.
Scott GK; Chang CH; Erny KM; Xu F; Fredericks WJ; Rauscher FJ; Thor AD; Benz CC
Oncogene; 2000 Dec; 19(55):6490-502. PubMed ID: 11175365
[TBL] [Abstract][Full Text] [Related]
15. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells.
Kujoth GC; Robinson DF; Fahl WE
Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620
[TBL] [Abstract][Full Text] [Related]
16. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
[TBL] [Abstract][Full Text] [Related]
17. The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements.
Böttinger EP; Shelley CS; Farokhzad OC; Arnaout MA
Mol Cell Biol; 1994 Apr; 14(4):2604-15. PubMed ID: 7511209
[TBL] [Abstract][Full Text] [Related]
18. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
Martin ME; Yang XY; Folk WR
Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
[TBL] [Abstract][Full Text] [Related]
19. Identification and analysis of the chicken c-mil promoter: possible involvement of Sp1- and Ets-related proteins.
Ansieau S; Plaza S; Ferreira E; Dozier C; Stéhelin D
Genomics; 1993 Dec; 18(3):537-45. PubMed ID: 8307563
[TBL] [Abstract][Full Text] [Related]
20. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
